Cosmap by MorphGen
FREN
Log in Request access

Cosmap, comprehensive and justified cosmetic screening, without proprietary data.

Cosmap turns your substitution problem into replacement pathways and ranked INCI candidates. Every suggestion is justified and can be corrected: the formulator stays in control.

It needs no proprietary data.

Request access 30 days of free access, on documented cases

An example on cyclotetrasiloxane (D4)

Cyclotetrasiloxane (D4) is a volatile silicone emollient, long used in skin care. It has been banned in cosmetics in the EU since June 2019, under Annex II of Regulation (EC) 1223/2009.

Here are the candidates Cosmap brings up, grouped by replacement strategy.

IngredientCYCLOTETRASILOXANE FunctionVolatile slip agent Product typeSkin care products

Saturated aliphatic hydrocarbons, linear or branched. Like D4, they evaporate after application.

IngredientReasonStatus
ISODODECANE Branched C12 alkane, MW 170. Emollient and solvent. no restriction
C10-13 ALKANE Decane to tridecane, BP 174–235 °C. Lipophilic solvent. no restriction
COCONUT ALKANES Plant-derived alkanes. Emollient and solvent. no restriction
C14-22 ALKANE Heavier alkane cut, non-volatile: behaves as a conventional emollient. flagged

Branched ethers and diesters. They give the slip and finish of D4 without evaporating; the film stays on the skin.

IngredientReasonStatus
DICAPRYLYL ETHER C16 dialkyl ether, MW 242. Emollient and solvent, with no ester function. no restriction
DIISOPROPYL SEBACATE Branched C16 diester, MW 286. Emollient, solvent and plasticiser. no restriction
NEOPENTYL GLYCOL DIHEPTANOATE Branched neopentyl diester, MW 328. Emollient. no restriction
PROPYLENE GLYCOL DIPELARGONATE Propylene glycol diester, MW 356. Emollient and viscosity controlling. no restriction

Illustrative example. The regulatory status and availability of each ingredient must be checked by the formulator.

The formulator's gain

Time. Cosmap does the surveying and the arguing in three to five minutes, across the 36,000 entries of the catalogue. What remains is to understand the ranking, choose, and refine the plan.

Your knowledge, taken into account. A process constraint, a family already ruled out in your lab: you correct the analysis, and the ranking follows.

Candidates the lab would not have listed on its own. The thirty are drawn from the whole catalogue, beyond what the team and its suppliers know.

Request access

We open Cosmap to you for 30 days, to explore several documented cases. This access is free.

Your data is processed by MorphGen to respond to your request and to follow up on our exchanges. You may object at any time. Learn more: legal notice.